Transthyretin and Receptor for Advanced Glycation End Product’s Differential Levels Associated with the Pathogenesis of Rheumatoid Arthritis
Monu,1,2 Prachi Agnihotri,1 Mohd Saquib,1,2 Ashish Sarkar,1,2 Debolina Chakraborty,1,2 Uma Kumar,3 Sagarika Biswas1 1Council of Scientific and Industrial Research -Institute of Genomics & Integrative Biology (CSIR–IGIB), Delhi, 110007, India; 2Academy of Scientific and Innovative Research (AcSIR...
Guardado en:
Autores principales: | Monu, Agnihotri P, Saquib M, Sarkar A, Chakraborty D, Kumar U, Biswas S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/93dcb46c30934decab06f175b744cf66 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
por: Cheng YZ, et al.
Publicado: (2014) -
Fluorescent serum and urinary advanced glycoxidation end-products in non- diabetic subjects
por: DE LA MAZA,MP, et al.
Publicado: (2007) -
Advanced glycation end products and oxidative stress as a basis for metabolic abnormalities in patients with type 1 diabetes after successful simultaneous pancreas-kidney transplantation
por: Irina I. Larina, et al.
Publicado: (2021) -
Inhibitory effect of lotus seedpod oligomeric procyanidins on advanced glycation end product formation in a lactose-lysine model system
por: Wu,Qian, et al.
Publicado: (2015) -
Inhibition of Advanced Glycation End Products in Yogurt by Lotus Seedpod Oligomeric Procyanidin
por: Nianjie Feng, et al.
Publicado: (2021)